HEGGIE THERESA - Insider Non-Derivative Transactions at BIOCRYST PHARMACEUTICALS INC (BCRX) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jun 14, 2024, HEGGIE THERESA's relationship to BIOCRYST PHARMACEUTICALS INC (BCRX) is Director, and currently has 52,852 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other BCRX insiders.

Data Source: SEC.
HEGGIE THERESA - Insider Non-Derivative Transactions of BCRX Common Stock
HEGGIE THERESA - Insider Non-Derivative Transactions at BCRX
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jun 15, 2024 Sell -- (Common Stock) 6698 6.11 52852
Jun 13, 2024 Acquisition -- (Common Stock) 6820 0 59550
Jun 1, 2024 Acquisition -- (Common Stock) 870 6.46 52730
Mar 1, 2024 Acquisition -- (Common Stock) 999 5.63 51860
Dec 1, 2023 Acquisition -- (Common Stock) 956 5.88 50861
Sep 1, 2023 Acquisition -- (Common Stock) 791 7.11 49905
Jun 14, 2023 Acquisition -- (Common Stock) 16745 0 49114
Jun 1, 2023 Acquisition -- (Common Stock) 680 8.27 32369
Mar 1, 2023 Acquisition -- (Common Stock) 635 8.85 31689